Veradigm Inc. (NASDAQ:MDRX – Get Free Report)’s share price gapped up prior to trading on Tuesday . The stock had previously closed at $9.40, but opened at $10.00. Veradigm shares last traded at $10.00, with a volume of 3,447 shares traded.
Wall Street Analyst Weigh In
Separately, StockNews.com assumed coverage on shares of Veradigm in a research note on Thursday, December 19th. They set a “hold” rating for the company. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $11.75.
View Our Latest Stock Analysis on MDRX
Veradigm Stock Down 0.5 %
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC purchased a new position in Veradigm Inc. (NASDAQ:MDRX – Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 3,974 shares of the software maker’s stock, valued at approximately $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
- Five stocks we like better than Veradigm
- What is Short Interest? How to Use It
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- Election Stocks: How Elections Affect the Stock Market
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.